Ohara Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ohara Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ohara Pharma Today - Breaking & Trending Today

Promise of new druggable targets drives Lilly into $660M Prism BioLab pact

Published: November 30, 2023

The discovery collab between Lilly and Prism, worth north of $600 million, promises to yield fresh targets that are readily druggable with small molecules.

Source: mmm-online.com

Related Topics:

Mablink BioscienceDai TakeharaOhara PharmaEli LillyPrism BiolabTokyo Based OharaShenzhen Based XtalpiPoint BiopharmaSigilon TherapeuticsDice Therapeutics